These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 19799638)

  • 1. Identification of salivary components that induce transition of hyphae to yeast in Candida albicans.
    Leito JT; Ligtenberg AJ; Nazmi K; Veerman EC
    FEMS Yeast Res; 2009 Oct; 9(7):1102-10. PubMed ID: 19799638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valinomycin affects the morphology of Candida albicans.
    Watanabe H; Azuma M; Igarashi K; Ooshima H
    J Antibiot (Tokyo); 2005 Dec; 58(12):753-8. PubMed ID: 16506692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-dodecanol (decyl methyl carbinol) inhibits hyphal formation and SIR2 expression in C. albicans.
    Lim CS; Wong WF; Rosli R; Ng KP; Seow HF; Chong PP
    J Basic Microbiol; 2009 Dec; 49(6):579-83. PubMed ID: 19810039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of inhibitors of yeast-to-hyphae transition in Candida albicans by a reporter screening assay.
    Heintz-Buschart A; Eickhoff H; Hohn E; Bilitewski U
    J Biotechnol; 2013 Mar; 164(1):137-42. PubMed ID: 23262131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory activity of thymol against the formation and viability of Candida albicans hyphae.
    Braga PC; Alfieri M; Culici M; Dal Sasso M
    Mycoses; 2007 Nov; 50(6):502-6. PubMed ID: 17944714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida albicans PHO81 is required for the inhibition of hyphal development by farnesoic acid.
    Chung SC; Kim TI; Ahn CH; Shin J; Oh KB
    FEBS Lett; 2010 Nov; 584(22):4639-45. PubMed ID: 20965180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol impaired the morphological transition of Candida albicans under various hyphae-inducing conditions.
    Okamoto-Shibayama K; Sato Y; Azuma T
    J Microbiol Biotechnol; 2010 May; 20(5):942-5. PubMed ID: 20519919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalase gene disruptant of the human pathogenic yeast Candida albicans is defective in hyphal growth, and a catalase-specific inhibitor can suppress hyphal growth of wild-type cells.
    Nakagawa Y
    Microbiol Immunol; 2008 Jan; 52(1):16-24. PubMed ID: 18352908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic interplay of Swi1 and Tup1 on filamentous growth of Candida albicans.
    Mao X; Li Y; Wang H; Cao F; Chen J
    FEMS Microbiol Lett; 2008 Aug; 285(2):233-41. PubMed ID: 18564337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LAAE-14, a new anti-inflammatory drug, increases the survival of Candida albicans-inoculated mice.
    Lucas R; Villamón E; Payá M; Alves M; del Olmo E; Gozalbo D; Gil ML
    FEMS Immunol Med Microbiol; 2004 Apr; 40(3):239-42. PubMed ID: 15039100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nisin Z inhibits the growth of Candida albicans and its transition from blastospore to hyphal form.
    Le Lay C; Akerey B; Fliss I; Subirade M; Rouabhia M
    J Appl Microbiol; 2008 Nov; 105(5):1630-9. PubMed ID: 19146497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of Candida albicans yeast and hyphal cell wall and associated proteins.
    Ebanks RO; Chisholm K; McKinnon S; Whiteway M; Pinto DM
    Proteomics; 2006 Apr; 6(7):2147-56. PubMed ID: 16493703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans.
    Stokes C; Moran GP; Spiering MJ; Cole GT; Coleman DC; Sullivan DJ
    Fungal Genet Biol; 2007 Sep; 44(9):920-31. PubMed ID: 17251042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of diclofenac sodium in the dimorphic transition in Candida albicans.
    Ghalehnoo ZR; Rashki A; Najimi M; Dominguez A
    Microb Pathog; 2010; 48(3-4):110-5. PubMed ID: 20026399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation.
    Krasowska A; Murzyn A; Dyjankiewicz A; Łukaszewicz M; Dziadkowiec D
    FEMS Yeast Res; 2009 Dec; 9(8):1312-21. PubMed ID: 19732158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTIR spectroscopy as a potential tool to analyse structural modifications during morphogenesis of Candida albicans.
    Adt I; Toubas D; Pinon JM; Manfait M; Sockalingum GD
    Arch Microbiol; 2006 May; 185(4):277-85. PubMed ID: 16474951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quorum sensing and Candida albicans.
    Kruppa M
    Mycoses; 2009 Jan; 52(1):1-10. PubMed ID: 18983434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory effects of butyl alcohol extract of Baitouweng decoction on yeast-to-hyphae transition of Candida albicans isolates from VVC in alkaline pH environment].
    Zhang MX; Xia D; Shi GX; Shao J; Wang TM; Tang CC; Wang CZ
    Zhongguo Zhong Yao Za Zhi; 2015 Feb; 40(4):710-5. PubMed ID: 26137695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida albicans binds to saliva proteins selectively adsorbed to silicone.
    Holmes AR; van der Wielen P; Cannon RD; Ruske D; Dawes P
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):488-94. PubMed ID: 16997116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vacuolar dynamics during the morphogenetic transition in Candida albicans.
    Veses V; Gow NA
    FEMS Yeast Res; 2008 Dec; 8(8):1339-48. PubMed ID: 19054134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.